BOISE, Idaho (March 25, 2016) – An Idaho bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients was signed by Gov. Otter on Wednesday The House of Delegates Health and Welfare Committee introduced House Bill 481 (H481) on…
BOISE, Idaho (March 14, 2016) – An Idaho bill that would set the foundation nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients passed the Senate by an overwhelming margin today and now heads to the governor’s desk. The House of Delegates Health and…
BOISE, Idaho (Feb. 29, 2016) – An Idaho bill that would set the foundation nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients passed the House by an overwhelming margin today. The House of Delegates Health and Welfare Committee introduced House Bill 481 (H481)…
BOISE, Idaho (Feb. 18, 2016) – An Idaho bill introduced last week would set the foundation nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. The House of Delegates Health and Welfare Committee introduced House Bill 481 (H481) on Feb. 12. The legislation would…